Post on 30-Jul-2020
Dr Omenge Orang’o May 2020
1
Curriculum Vitae
Dr Orang’o Elkanah Omenge Senior Lecturer of Obstetrics and Gynaecology
Chair Division of Gynaecologic Oncology Moi University School of Medicine
Department of Reproductive Health Eldoret Gyne Group Moi University School of Medicine Waiganjo Street, Suite 17 P.O. BOX 4606 P.O. BOX 2522- 30100 Eldoret – 30100 Eldoret Kenya Kenya Tel: +254 722609132 E-mail: bworango@mu.ac.ke _____________________________________________________________________ BIOGRAPHICAL INFORMATION EDUCATION 2019 Doctor of Medical Sciences (PhD), University of Antwerp. 2014 Fellow in Gynaecologic Oncology- Moi University/University of Toronto 2012 Brown University USA (Fogarty Scholar) Research Methods in Clinical,
Translational and Health Services Research Summer 2012 University of Washington-USA- Principles of STD/HIV Research Course 2005: Master of Medicine in Obstetrics and Gynaecology (M-med, University of
Nairobi) 1998: Bachelor of Medicine, Bachelor of Surgery (MBChB, University of Nairobi) CLINICAL TRAINING: Sept 2012- August 2014 Fellowship training in Gynaecologic Oncology Feb 2010: 6-day training in emergency Obstetric care, ALARM International. Certified as
a trainer. 2008: Six weeks’ attachment at the Division of Gynaecological Oncology, Department
of Obstetrics and Gynaecology University of Toronto. 2002 – 2005: Resident Department of Obstetrics and Gynaecology, University of Nairobi. 2002 – 2005: Member of Royal College of Obstetrics and Gynaecology, UK. 1999 – 2000: Internship training at the Moi Teaching and Referral Hospital. 1992 – 1998: Medical Student University of Nairobi.
Dr Omenge Orang’o May 2020
2
PROFESSIONAL APPOINTMENTS A. Current Academic Positions 2015-July 2019: Chair, Department of Reproductive Health, Moi University School of
Medicine. 2014-Present: Head of Gynaecologic oncology at AMPATH Oncology Institute, Moi
University/Moi Teaching and Referral Hospital 2012- Present : Member, AMPATH Oncology Institute Steering Committee. 2009- Present: AMPATH Cervical Cancer Screening Program Director ( ACCSP) 2009 –Present: Senior lecturer department of Reproductive health, Moi University
School of Medicine. 2009 –present: Project manager- ALARM international Kenya, an emergency obstetric
care programme run by ASANTE- reproductive health, a partnership between MTRH, Moi University and University of Toronto.
B. Former Academic Appointments 2005 – 2009: Consultant Obstetrician Gynaecologist Moi Teaching and Referral
Hospital 2005 – 2009: Honorary Lecturer Moi University School of Medicine 2007 – Present: Part time Lecturer – Kenya Medical Training College (KMTC) Eldoret. 2006 – 2009: Head of Department – Reproductive Health Wards, Moi Teaching and
Referral Hospital. 2006 – 2012: Chairman Medical Records and Informatics Committee, Moi Teaching
and Referral Hospital. 2007 – Present: Vice chairman Continuous Professional Development – Moi Teaching
and Referral Hospital. C. Other Appointments 2000 – 2002: Medical Officer, Department of Obstetrics and Gynaecology Moi
Teaching and Referral Hospital. 2002 – 2005: Resident Kenyatta National Hospital 2003 – 2004: Resident; The Aga Khan University Hospital – Nairobi’
Dr Omenge Orang’o May 2020
3
2004 – 2005: Chief Resident Department of Obstetrics and Gynaecology University of Nairobi.
PUBLICATIONS
Journals Articles (Peer-reviewed)
1. Nassir F, Odongo BE, Itsura PM, Tonui P, Omenge O:Primary Mucinous Cystadenocarcinoma Of Ovary: Changing Treatment Paradigms,Journal of Obstetrics and Gynaecology of Eastern and Central Africa(JOGECA) (2020);32(1): 52
2. Omenge EO, Tong Y Tonui P, Ong’echa J, Muthoka K, Kiptoo S, Maina T, Itsura P, Moorman A, Wong Y, Ermel A Liu T, Hogan J, Loehrer P, Brown D, Cu-Uvin S Comparison of HPV detection in HIV-infected and HIV-uninfected Kenyan women with or without cervical dysplasia. Journal of Clinical Oncology (2019) 37(15_suppl) e17015-e17015 DOI: 10.1200/jco.2019.37.15_suppl.e17015
3. Philippe PA, Elly B, Cheruiyot A, Orang'o OE. Nasopharyngeal Carcinoma in Pregnancy: Management Approach Case Report at Moi Teaching and Referral Hospital, Eldoret-Kenya ISSN: 2471-8165
4. Philippe PA, Cheruiyot A, Shurie S, Pallavi M, Orang'o OE (2019) Early Second
Trimester Twin-to-Twin Transfusion Syndrome in Monoamniotic Twin Pregnancy: The Cause and Management – A Case Report from Resource Limited Settings. Gynaecology & Obstetrics Case Reports Vol.5 No.3:80 & Obstetric2471-8165
5. Omenge Orang’o, Naaman Mehta, Peter Itsura, Philip Tonui, Hermann Bussmann,
JP Bogers, Tao Liu, and Susan Cu-Uvin. Loop Electrosurgical Excision Procedure Treats Cervical Intraepithelial Neoplasia 2/3 Among HIV− and HIV+ Women in Kenya. Journal of Lower Genital Tract Disease • Volume 23, Number 4, October 2019
6. PA Philippe, EO Orang'o, FA Barasa
Factors Related to Congenital Heart Disease in Offspring from Women with Rheumatic Heart Disease: Case reports from Moi Teaching and Referral Hospital, Eldoret, Kenya Asploro Journal of Biomedical and Clinical Case Reports 2019 (3), 87
7. Benjamin O. Elly, Elkanah O. Orang’o, Itsura M Peter, Tonui P. Kipkirui, Hellen N.
Muliro1, Vincent N Oyiengo, Thomas Achia. Clinical-Pathological Presentation, Treatment and Outcomes of Ovarian Cancer Cases at Moi Teaching and Referral Hospital (MTRH), Eldoret. Journal of Obstetrics & Gynaecology of Eastern and Central Africa JOGEGA 2019; 31(2)
Dr Omenge Orang’o May 2020
4
8. Itsura M. Peter, Rachel N. Deraney, Omenge Orang’o, Tonui Philip, Barry Rosen, Susan Cu-Uvin. Radical hysterectomy for operable early cervical cancer in HIV-positive and HIV-negative women in western Kenya. Int J Gynecol Obstet 2019; 1–2 wileyonlinelibrary.com/journal/ijgo
9. Ermel, P. Tonui, M. Titus, Y. Tong, N. Wong, J. Ong’echa, K. Muthoka, S. Kiptoo, A. Moormann, J. Hogan, A. Mwangi, S. Cu-Uvin, P. J. Loehrer, O. Orang’o and D. Brown. A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women BMC Infectious Diseases (2019) 19:352 https://doi.org/10.1186/s12879-019-3982-7
10. Jianjun Zhang, Omenge Orang’o, Philip Tonui, Yan Tong, Titus Maina, Stephen Kiptoo, Katpen Muthoka, John Groopman, Joshua Smith, Erin Madeen, Aaron Ermel, Patrick Loehrer, Darron R. Brown
Detection and
Concentration of Plasma Aflatoxin Is Associated with Detection Of Oncogenic Human Papillomavirus In Kenyan Women Open Forum Infectious Diseases, ofz354, https://doi.org/10.1093/ofid/ofz354
11. Sahara Shurie, Luhumyo Loice, Odongo Benjamin Elly, Emmanuel Wekesa Wamalwa, Oyiengo Vincent, Keitany Kibor Kibet, Orang’o Elkanah Omenge and Muliro Hellen. Subcutaneous Metastasis of Cancer of the Endometrium: Case Report. Oncol Case Report J. 2019; 2(1): 1008
12. Sahara Shurie, Edwin Were, Omenge Orang’o, Alfred Keter
Levonorgestrel only emergency contraceptive use and risk of ectopic pregnancy in Eldoret Kenya: a case-control study Pan African Medical Journal. 2018; 31:214. doi:10.11604/pamj.2018.31.214.17484
13. Oyiengo V.N, Omenge E. Orang’o, Itsura P.M, Philip K. Tonui, Benjamin E. Odongo, Emmanuel W. Wamalwa Prenatal Cervical Cancer Screening Using Visual Inspection with Acetic Acid in a Low Resource Setting. Indian Journal of Gynecologic Oncology (2018) 16:64 https:/doi.org/10.1007/s409- 018-0235-4
14. Darron R Brown, Titus Maina, Philip Tonui, John M Ong’echa, Aaron Ermel, Kapten
Muthoka, Stephen Kiptoo, Yan Tong, YeungChing Wong, Ann Moormann, Ann Mwangi, Joseph Hogan, Patrick J Loehrer, Elkanah Omenge Orang’o AMPATH Oncology: Baseline HPV detection in Kenyan women enrolled in a longitudinal study of modifiable factors predicting cervical dysplasia. Journal of Clinical Oncology 36 (15_suppl), 5533-5533
15. Hillary Mabeya, Sonia Menon, Steven Weyers, Violet Naanyu, Emily Mwaliko, Elijah Kirop, Omenge Orang’o, Heleen Vermandere and Davy Vanden Broeck
Dr Omenge Orang’o May 2020
5
Uptake of three doses of HPV vaccine by primary school girls in Eldoret, Kenya; a prospective cohort study in a malaria endemic setting
16. Patrick J Loehrer Sr, Barry Rosen, Elkanah Omenge Orang’o, Julie R Gralow
Capacity building in sub-Saharan Africa: models of care www.thelancet.com/lancetgh, Published Online March 1, 2018
17. S Kiptoo, G Otieno, P Tonui, A Mwangi, O Orang’o, P Itsura , K Muthoka, J Oguda, B Rosen, P Loehrer, S Cu-Uvin Loss to Follow-Up in a Cervical Cancer Screening and Treatment Program in Western Kenya Journal of Global Oncology, 97s-97s
18. S Kirui, K Patel, O Orang’o Prevalence of high risk HPV in HIV+ and HIV-women
with cervical dysplasia at the Moi Teaching and Referral Hospital East African Medical Journal 94 (11), 891-900
19. G Ganda, P Itsura, P Tonui, J Namugga, O Omenge, B Rosen
Perioperative Complications Of Radical Hysterectomy At Moi Teaching And Referral Hospital, A Low Resource Setting-A 5 Year R... International Journal of Gynaecological Cancer 26, 344-344
20. Mwaniki Grace Nyambura1, James N. Kiarie2, Omenge Orang’o1Knowledge and
Utilisation of Emergency Contraception Pills among Female Undergraduate Students at the University of Nairobi, Kenya Open Journal of Obstetrics and Gynaecology 7 (09), 989-1005
21. B Rosen, P Itsura, P Tonui, A Covens, L van Lonkhuijzen, EO Orang'o
Development of a comprehensive and sustainable gynaecologic oncology training program in western Kenya, a low resource setting Gynecologic oncology reports 21, 122-127
22. Thomas C. Randall, Linus Chuang, Elkanah Omenge Orang'o, Barry Rosen,
Francois Uwinkindi, Timothy Rebbeck, Edward L. Trimble, Strengthening care and research for women's cancers in Sub-Saharan Africa. Gore (2017), doi: 10.1016/j.gore.2017.06.002
23. Elkanah Omenge Orang’o, Tao Liu, Astrid Christoffersen-Deb, Peter Itsura, John
Oguda, Sierra Washington, David Chumba, Latha Pisharodi, Susan Cu-Uvin, Anne
F Rositch Use of visual inspection with acetic acid, Pap smear, or high-risk human
papillomavirus testing in women living with HIV/AIDS for posttreatment cervical
cancer screening: same tests, different priorities. AIDS: 14 January 2017 - Volume
31 - Issue 2 - p 233–240 doi: 10.1097/QAD.0000000000001327 Clinical Science
24. Elkanah Orang’o, Peter Itsura, Philip Tonui, Hellen Muliro, Barry Rosen, and Luc van Lonkhuijzen, Use of Palliative Cisplatinum for Advanced Cervical Cancer in a Resource-Poor Setting: A Case Series From Kenya, DOI: 10.1200/JGO.2016.006411 Journal of Global Oncology - published online before print November 2, 2016
Dr Omenge Orang’o May 2020
6
25. Aaron Ermel, Brahim Qadadri, Yan Tong, Omenge Orang’o, Benson Macharia,
Doreen Ramogola-Masire, Nicola M. Zetola and Darron R. Brown Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications, infectious Agents and Cancer 2016 11:56 DOI: 10.1186/s13027-016-0102-9 © The Author(s). 2016
26. Orang’o EO, Wachira J, Asirwa FC, Busakhala N, Naanyu V, Kisuya J, et al. (2016)
Factors Associated with Uptake of Visual Inspection with Acetic Acid (VIA) for Cervical Cancer Screening in Western Kenya. PLoS ONE 11(6): e0157217. doi: ‘10.1371/journal.pone.0157217
27. Naanyu V, Asirwa CF, Wachira J, Busakhala N, Kisuya J, Otieno G, Keter A,
Mwangi A, Omenge OE, Inui T. Lay perceptions of breast cancer in Western Kenya. World J Clin Oncol. 2015 Oct 10; 6(5): 147-55. doi: 10.5306/wjco. v6. i5.147. %
28. Kisuya J, Wachira J, Busakhala N, Naanyu V, Chite AF, Omenge O, Otieno G,
Keter A, Mwangi A, Inui T. Impact of an educational intervention on breast cancer knowledge in western Kenya. Health Educ Res. 2015 Oct; 30(5): 786-96. doi: 10.1093/her/cyv043. Epub 2015 Sep 3.
29. Spitzer RF, Steele SJ, Caloia D, Thorne J, Bocking AD, Christoffersen-Deb A, Yarmoshuk A, Maina L, Sitters J, Chemwolo B, Omenge E. One-Year Evaluation Of The Impact Of An Emergency Obstetric And Neonatal Care Training Program In Western Kenya. Int J Gynaecol Obstet. 2014 Nov; 127(2): 189-93. Doi: 10.1016/J.Ijgo.2014.05.023. Epub 2014 Jul 17
30. Ngichabe S. K, Muthaura P. N, Murungi C., Muyoka J, Omenge E, And Muchiri L.
Cryotherapy Following Via/Vili In Khwisero Western Kenya: Lesson from The Field
Affecting Policy and Practice. East African Medical Journal Vol. 90 No. 10 October
2013
31. Kareem Khozaim, Elkanah Orang’o, Astrid Christoffersen-Deb, Peter Itsura, John Oguda, Hellen Muliro, Jackline Ndiema, Grace Mwangi, Matthew Strother, Susan Cu-Uvin, Barry Rosen, Sierra Washington. Success and challenges of establishing a cervical cancer screening and treatment program in Western Kenya. International Journal of Gynaecology & Obstetrics Volume 124, Issue 1, Pages 12-18, January 2014
32. Alice Gray, Christe Henshaw, Julie Wright, Jessica Leah, David Caloia, Rachel F.
Spitzer, Elkanah O. Orang’o, Benjamin Chemwolo, William M. Tierney. Effect of
EMR Implementation On Clinic Time, Patient and Staff Satisfaction, and Chart
Completeness In a Resource-Limited Antenatal Clinic In Kenya Studies in Health
Technology and Informatics Volume 192: MEDINFO 2013
33. R.M. Strother, F.C. Asirwa, N.B. Busakhala, E. Njiru, E.O. Orang’o, F. Njuguna, J. Skilles, J. Carter, A. Mega, G.J.L. Kaspers, B. Rosen, M.K. Krzyzanowska, S.
Dr Omenge Orang’o May 2020
7
Washington, A. Griest, A. Rosmarin, P.J. Loehrer. AMPATH-Oncology: A model for comprehensive cancer care in sub-Saharan Africa. Journal of Cancer Policy 1(2013) e42-e48
34. R.M. Strother, F.C. Asirwa, N.B. Busakhala, E. Njiru, E.O. Orang’o, F. Njuguna, J.
Skilles, J. Carter, A. Mega, G.J.L. Kaspers, B. Rosen, M.K. Krzyzanowska, S. Washington, A. Griest, A. Rosmarin, P.J. Loehrer. The evolution of comprehensive cancer care in Western Kenya. Journal of Cancer Policy 1(2013) e25-e30
35. Mabeya H, Khozaim K, Liu T, Orang’o O, Chumba D, Pisharodi L, Carter J, Cu-Uvin
S. Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western Kenya. J Low Genit Tract Dis. 2012 Apr; 16(2): 92-7. PMID: 2212683.
36. Lynch C, Omenge E, Itsura P, Muliro H, Delpriore G, Rosen B, Washington S,
Strother M, Cervical Cancer treatment for operable in a low-resource contemporary setting. J Clin Oncol 30, 2012 (suppl; abstr 5107)
37. Lynn Sterling, Luc van Lonkhuijzen, MD, Job Nyangena, Elkanah Orang’o, MD,
Matthew Strother, MD, Nafthali Busakhala, MD, and Barry Rosen, MD, FRCSC Protocol Development for Ovarian Cancer Treatment in Kenya A Brief Report Int J Gynecol Cancer 2011; 21: 424-427
38. Aurie M. Elit, MD, Barry Rosen, MD, Waldo Jimenez, MD, Christopher Giede, MD, Paulina Cybulska, MD, Sarah Sinasac, Jason Dodge, MD, Erdenejargal Ayush, MD, Orang’o Omenge, Marcus Bernardini, MD, Sarah Finlayson, MD, Jessica McAlpine, MD, Dianne Miller, MD, and for the International Community of Practice Committee of the Society of Gynecologic Oncology of Canada. Teaching Cervical Cancer Surgery in Low- or Middle-Resource Countries. Int J Gynecol Cancer 2010; 20: 1604-1608.
39. S. Sinasac S, Taleski Spitzer R, Omenge E, Job satisfaction among physicians and
nurses in a teaching and referral hospital in Western Kenya: Do partnerships with high resource institutions in North America make a difference? Int J of Gynaecology & Obstetrics 107S2 (2009) S93–S396
40. Yarmoshuk A, Bocking A, Spitzer R, Caloia D, Orang’o E, Were E, Einterz R,
Mabeya H, Improving women’s reproductive health in Western Kenya: A North American/African academic model. Int J of Gynaecology & Obstetrics 107S2 (2009) S413–S729
B. Manuscript in ProgressOo
1. E. O Orang’o, T. Liu, P. Itsura, AF. Rositch, S. Cu-Uvin. Association of Cryotherapy and HIV1 Genital Shedding.
C. Abstracts / Conference Presentations
2. Benjamin Elly, Barry Rosen, Oyiengo VN, Omenge E.O, Tonui P.K, Itsura M.P. Epithelial Ovarian Cancer at MTRH, An Institutional Experience: A
Dr Omenge Orang’o May 2020
8
Descriptive Analysis of data, 2010-2016 Presented at The 41st KOGS Annual Scientific Conference in Mombasa
3. Omondi P, Odongo BE, Itsura MP, Omenge EO, Tonui PK, Keitany K,
Metastatic Gestational Choriocarcinoma in a viable near-term pregnancy – Presented in the 43rd KOGS annual Scientific Conference February 2019, MovenPick Hotel and Residences, Nairobi
4. Shurie S, Luhumuyo L, Odongo E, Oyiengo V, Orang’o O, Muliro H
Subcutaneous metastasis of cancer of the endometrium at a tertiary facility in Kenya: a case report – Presented in the 43rd KOGS annual Scientific Conference February 2019, MovenPick Hotel and Residences, Nairobi- Oral presentation
5. Omenge Orang’o1, Gad Murenzi2, Philip Castle3, Susan Cu-Uvin4, Robert D.
Burk5. HPV Infection and Vaginal Microbiome Diversity in HIV-Infected and Uninfected Women in Kenya and Rwanda, April 25-27, 2018, NCI U54 Meeting, Lilongwe, Malawi
6. Omenge Orang’o1; Susan Cu-Uvin2; Tao Liu3; P Itsura1, P Tonui1, B Rosen3, P Loehrer4, The impact of VIA screen and treatment with cryotherapy or LEEP in patients with HIV-infected and HIV-uninfected patients with cervical intraepithelial neoplasia (CIN). April 25-27, 2018, NCI U54 Meeting, Lilongwe, Malawi.
7. Omenge Orang’o, Barry Rosen. Building Capacity/Sustainability for
Comprehensive Cancer Care in a Low Resource Country Toronto Global Cancer Control Conference, March 1 to 3rd 2018, Toronto, Canada
8. EO Omenge, Rositch AF, Tao L, Itsura P, Tonui P, Cu-Uvin S. Post-LEEP
follow-up by VIA and PAP Smear in HIV-Positive and HIV-Negative Women in Western Kenya AORTIC 2017, Kigali, Rwanda, 7-10 November 2017. Abstract number 448- Poster presentation.
9. E.O Orang’o, E. Were, S. Kiptoo, K. Muthoka, D. vanden Broeck, M. von
Knebel Doeberitz, H. bussmann Comparison of VIA with molecular testing using HPV DNA and the biomarker p16INK4a/Ki67 for cervical cancer screening in a high prevalent cervical cancer setting. Eurogin 2017, Amsterdam, Netherlands, October 08-11, 2017, Abstract number #00529 - Oral presentation
10. Orang’o E. Omenge, Were E, Von Knebel, Doeberitz, Bussmann H,
byczkowski E. Design and Implementation of an electronic data system for cervical cancer Screening in peripheral settings in Kenya. Eurogin 2017, Amsterdam, Netherlands, October 08-11, 2017, Abstract number #00526- Accepted for oral presentation
Dr Omenge Orang’o May 2020
9
11. Barry Rosen MD. Elkanah Omenge Orang’o, MD, Peter Itsura MD, Phillip
Tonui MD. Building Capacity in Gynaecologic Oncology in Kenya. The 48TH SGO Annual Meeting, National Harbor, MD, March 12-15
12. Barry Rosen MD, Elkanah Omenge Orang’o MD, Peter Itsura MD, Phillip
Tonui MD. Home HPV testing in rural Kenya; Improving capacity for cervical cancer screening and prevention, The 48TH SGO Annual Meeting, National Harbor, MD, March 12-15
13. Elkanah Omenge Orang’o, Susan Cu-Uvin Tao Liu P Itsura, P Tonui, B
Rossen, P Loehrer, The impact of VIA screen and treatment with cryotherapy or LEEP in patients with HIV-infected and HIV-uninfected patients with cervical intraepithelial neoplasia (CIN). Sub-Saharan African Collaborative HIV and Cancer Scientific Symposium. Boma Inn, Eldoret, March 21ST – 24TH 2017
14. Elkanah Omenge Orang’o, Peter Itsura, Darron Brown, Susan Cu-Uvin, Pat
Loehrer. The AMPATH-Oncology Institute: Longitudinal Analysis of HPV and Cervical Cancer in Kenyan Women with HIV/AIDS, Sub-Saharan African Collaborative HIV and Cancer Scientific Symposium. UCI-Fred Hutch Cancer Center, Uganda Cancer Institute, Upper Mulago Hill Road, Kampala, Uganda. January'19-21, 2016
15. Omenge E. Orang’o, T. Liu, P. Itsura, A. Christoffersen-deb, S. Washington,
J. Oguda, S. Cu-Uvin, A. Rositch. VIA, PAP Smear and HR-HPV Testing in Women with HIV/AIDS for Post-Treatment Cervical Cancer Screening: Same Tests, Different Priorities. Abstract Number: HPV17-0044 31St International Papillomavirus Conference- HPV 2017, Cape Town, South Africa, February 28- March 4, 2017
16. Orang’o O, Itsura P, Kaaria A, Tonui P, Cu-Uvin S Ermel A, Moormann A, Ong’echa J, Rosen B, Flick N, Tu W, Hogan J, Brown D and Loehrer P. An interim report on the AMPATH-Oncology Institute: Longitudinal Analysis of HPV and Cervical Cancer in Kenyan Women with HIV/AIDS. 41ST Annual Scientific Conference of the Kenya Obstetrical and Gynaecological Society (KOGS), PrideInn Paradise Beach Resort & Spa, Mombasa, 15th- 17th February 2017.
17. Orang’o E. Omenge, Itsura P, Tonui P, Ganda G, Namugga J, Onyiengo,
Rosen B, Luc L. Palliative Cisplatinum for advanced cervical cancer: A case of MTRH. 41ST Annual Scientific Conference of the Kenya Obstetrical and Gynaecological Society (KOGS), PrideInn Paradise Beach Resort & Spa, Mombasa, 15th- 17th February 2017.
18. Omenge E. Orang’o, Itsura P, Tonui P, Ganda G, Namugga J, Onyiengo,
Factors Associated with Uptake of Cervical Cancer Screening in Western Kenya. 41ST Annual Scientific Conference of the Kenya Obstetrical and Gynaecological Society (KOGS), PrideInn Paradise Beach Resort & Spa, Mombasa, 15th- 17th February 2017.
Dr Omenge Orang’o May 2020
10
19. Omenge E. Orang’o, Barry Rosen, Ulmesh Mahantshetty, Michael Milosevic, Ophira Ginsburg. Cervical Cancer from Early Diagnosis to Advanced Disease: Lofty Goals and on-the-ground Realities. 2016 World Cancer Congress, Paris, France, 31St October- 3Rd November 2016.
20. Danielle Chau, Omenge E. Orang’o, P. Itsura, P. Tonui, T. Liu, S. Cu-Uvin. Post-LEEP Surveillance in HIV-Positive and HIV-Negative Women in Western Kenya. Abstract Number IGCS-1011. 16Th Biennial Meeting of the International Gynecologic Cancer Society (IGCS), Lisbon, Portugal, October 29- 31, 2016.
21. Elkanah Omenge Orang’o, D. Brown, A. Ermel, Y. Tong, B. Qadadri, G.
Wilson, and B. Macharia. Invasive Cervical Cancers Among Kenyan Women: HPV type Distribution and Implications for Choice of HPV Vaccine. 1st AFOG & 39Th KOGS Annual Scientific Conference, Safari Park Hotel, Nairobi, February 18Th-20Th 2015.
22. Omenge E. Orang’o, Keynote Address: Burden of Disease in Gynaecologic
Oncology: How can we impact Outcomes? KOGS Coast 5TH Annual Symposium, Pandya Memorial Hospital, Mombasa, 17TH – 18TH 2014
23. Omenge E. Orang’o, Principles of management in Early Stage Cervical
Cancer, Keynote speaker, Society of Obstetrics and Gynaecology of Rwanda, 4TH Annual scientific Conference, King Faisal Hospital, Kigali Rwanda, July 14TH – 16TH 2014.
24. Omenge E. Orang’o, Introduction to colposcopy. Society of Obstetrics and
Gynaecology of Rwanda, 4TH Annual scientific Conference, King Faisal Hospital, Kigali Rwanda, July 14TH – 16TH 2014.
25. E. Omenge, T. Liu, P. Itsura, H. Mabeya, A. Christoffersen-deb, S.
Washington, J. Oguda, S. Cu-Uvin Visual Inspection with Acetic Acid (VIA) Agrees Reasonably Well with Pap Smear for Follow-up After VIA/Cryotherapy in HIV-infected Women. Conference on Retroviruses and Opportunistic Infections (CROI 2014) March 2-6, 2014 at the Hynes Convention Centre in Boston, Massachusetts.
26. Peter Itsura; Elkanah Omenge; Hellen Muliro; Luc van Lonkhuijzen; Barry
Rosen Neoadjuvant Cisplatin for Cervical Cancer at Moi Teaching and Referral Hospital, Eldoret, Kenya: Two-Year Experience. AORTIC 2013|DURBAN|21–24 NOVEMBER 2013
27. Luc van Lonkhuijzen; Peter Itsura; Elkanah Omenge; Hellen Muliro; Barry
Rosen Cisplatin for The Palliative Treatment of Cervical Cancer at Moi Teaching and
Referral Hospital, Eldoret, Kenya: A Two-Year Experience. AORTIC
2013|DURBAN|21–24 NOVEMBER 2013
Dr Omenge Orang’o May 2020
11
28. Elkanah Orang’o; Peter Itsura; John Oguda; Hellen Muliro;Fredrick Asirwa;
Matthew Strother; Astrid DebChristopherson;Luc van Lonkhuijzen; Patrick
Loehrer; Barry Rosen Developing a Comprehensive Approach to Cervix
Cancer in Africa: Is It Possible? AORTIC 2013|DURBAN|21–24
NOVEMBER 2013
29. Elkanah Orang’o; Peter Itsura; John Oguda; Kapten Mwendwa;Luc van
Lonkhuijzen; Barry Rosen. A Multifaceted Intervention to Reduce Loss to Follow Up in A Cervical Cancer Screening Programme. AORTIC 2013|DURBAN|21–24 NOVEMBER 2013
30. E. Omenge1, P. Itsura1, T. Liu4 H. Mabeya1, A. Christoffersen-Deb1,2, S. Washington3, S. Cu-Uvin4. Six-Month Follow-up of HIV-infected Women After Visual Inspection with Acetic Acid (VIA) and Immediate Cryotherapy in Western, Kenya. Abstract #: T-116. 20th Conference on Retroviruses and Opportunistic Infections (CROI) March 3-6, 2013 at Georgia World Congress Centre in Atlanta.
31. Omenge Orango1, Hellen Muliro2, Peter Itsura2, PhillipTonui2, Brendan3,
Barry Rosen3.Clinical Epidemiology and Management of Gestational Trophoblastic Neoplasia in Moi Teaching and Referral Hospital in the Last 2 Years. Presented at the 37th Annual Scientific Conference of the Kenya Obstetrical and Gynaecological Society (KOGS) held at Hotel Sirikwa, Eldoret on 13th to 15th February 2013.
32. E. Omenge, R. Spitzera, S. Taleskib, D. Caloiaa J. Thornea, A. Bockinga, A.
Christoffersen-Deba, d, A. Yarmoshuka, L. Mainac, J. Sittersc, B. Chemwolo c Evaluation of the Impact of an Emergency Obstetric and Neonatal Care (EMONC) Training Program at a Referral Centre in Kenya. Presented at the 37th Annual Scientific Conference of the Kenya Obstetrical and Gynaecological Society (KOGS) held at Hotel Sirikwa, Eldoret on 13th to 15th February 2013.
33. Nyongesa Paul1, Omenge Orango1, Itsura Peter2, Barry Rosen3
Development of Innovative Sub-Specialty Training in Gynaecologic Oncology for Low and Middle-Income Countries. Presented at the 37th Annual Scientific Conference of the Kenya Obstetrical and Gynaecological Society (KOGS) held at Hotel Sirikwa, Eldoret on 13th to 15th February 2013.
34. Muthoka Kapten 1
, Oguda John1, Were Clive1, Peter Itsura1, Omenge Orang’o2 Improving access to Cervical Cancer Screening Services among HIV Positive Women in Western Kenya through Community Outreach Clinics. Presented at the 37th Annual Scientific Conference of the Kenya Obstetrical and Gynaecological Society (KOGS) held at Hotel Sirikwa, Eldoret on 13th to 15th February 2013.
35. Clive Were1, John Oguda1, Kapten Mwendwa1, Peter Itsura1, Omenge
Orang’o2 Reducing Loss to Follow-Up Among Cryotherapy and Colposcopy Clients in the Cervical Cancer Screening Program. Presented at the 37th Annual Scientific
Dr Omenge Orang’o May 2020
12
Conference of the Kenya Obstetrical and Gynaecological Society (KOGS) held at Hotel Sirikwa, Eldoret on 13th to 15th February 2013.
36. Alice Graya, Christe Henshawa, Julie Wrighta, Jessica Leaha, David Caloiaa,
Rachel F. Spitzera, Omenge Orang’o, Benjamin Chemwolob, William M. Tierneyc Effect of EMR Implementation on Clinic Time, Patient and Staff Satisfaction, and Chart Completeness In a Resource-Limited Antenatal Clinic In Kenya. Presented at the 37th Annual Scientific Conference of the Kenya Obstetrical and Gynaecological Society (KOGS) held at Hotel Sirikwa, Eldoret on 13th to 15th February 2013.
37. E. Omenge1, P. Itsura1, H. Mabeya1, C. Astrid2, J. Oguda1, H. Muliro1, S.
Washington, S. Cu-Uvin3, B. Rosen2. Cost of Cervix Cancer Screening in a Low Resource Setting in Africa. UICC 2012 World Cancer Congress August 27-30, 2012, Montreal, Canada.
38. B. Rosen, E. Omenge, P. Itsura.
Development of the Gynaecologic Oncology Program in Kenya. UICC 2012 World Cancer Congress August 27-30, 2012, Montreal, Canada.
39. B. Rosen, E. Omenge, P. Itsura.
Development of a cervical cancer-screening program in western Kenya. UICC 2012 World Cancer Congress August 27-30, 2012, Montreal, Canada.
40. C.Lynch, E. Omenge, P. Itsura, H. Muliro, B. Rosen, G. Del Priore, S.
Washington, R. Sthrother. Cervical Cancer Treatment for Opereable lesions in a low resource contemporary setting. 14th Biennial meeting of the International Gynaecologic Cancer Society (IGCS), Vancouver, Canada, Oct 13-16, 2012.
41. P. Itsura, E. Omenge, H. Muliro, C. Lynch, B. Rosen
Outcomes from a radical hysterectomy-training program in a low resource setting.
14th Biennial meeting of the International Gynaecologic Cancer Society (IGCS), Vancouver, Canada, Oct 13-16, 2012.
42. Orang’o O.1Mabeya H.1, Khozaim K.2, Liu T.3, Chumba D.1, Pisharodi L.3,
Cu-Uvin S.3 Comparison of Conventional Pap smear and Visual Inspection with Acetic Acid (VIA) in HIV-Infected Women in Western Kenya. Presented at the 1st Sub-Saharan Africa CFAR Conference; Kampala Uganda May 6th to 8th 2011.
43. B Rosen, J Dodge, C Giede, W. Jimenez. P Cibulska, S Sinesat, M
Bernardini, J McAlpine, S Finlayson D Miller, Omenge O, P Itsura, L. Elit Implementation of Oncology Surgery in Western Kenya The Society of Pelvic Surgeons, Toronto, Ontario, Canada
44. Elkanah Omenge (3). Heather C. Miller {M} (1, Rachel F. Spitzer 1, 2),
Mathew Sermer (1, 2), Hillary Mabeya (3), University of Toronto; (2)
Dr Omenge Orang’o May 2020
13
Understanding the Burden of Cardiac Disease Among Pregnant Women at The Moi Teaching and Referral in Eldoret, Kenya: A Retrospective Review. Presented at Moi University 5th Annual International Conference, book of Abstract 4#035.
45. Elkanah O. Omenge (2). Sarah E. Sinasac {R} (1), Sarah J. Taleski (3), Rachel
F. Spitzer (1) Job Satisfaction Among Physicians and Nurses in A Teaching ]and Referral Hospital in Western Kenya: Do Partnerships With High Resource Institutions In North America Make A Difference? Presented at Moi University 5Th Annual International Conference, Book of Abstracts, 4#40; 4Th August 2009 – 8Th August 2009.
46. Omenge E; Oyieke JBO; Kudoyi W;
Management and Outcome of Patients with One Previous Caesarean Section at Moi Teaching and Referral Hospital, Eldoret, Kenya. Presented at the Kenya Obstetrical and Gynaecological Society (KOGS) 29th Annual Scientific Conference, Merica Hotel Nakuru, 23rd to 25th February 2005.
47. Omenge E; Oyieke JBO, Kudoyi W;
Norplant Contraceptive Implants: Reasons for Removal and Discontinuation Among Users As Seen At The Moi Teaching And Referral Hospital Family Welfare Clinic. Submitted for Mmed Thesis University of Nairobi, 2005.
48. Aaron Y (1); Omenge E. (2); Caloia D (1); Alan B (1); Mabeya H (2); Were E
(3); Rachel S (1) Improving Women’s Reproductive health in Western Kenya: A North American/ African Academic Model. Presented at the Federation Internationalle for Obstetricians and Gynaecologists (FIGO) – Oct 2009, Cape Town South Africa.
Post Graduate Thesis Supervision 1. Mary Gathogo – Reg. No. SM/PGRH/05/13 MMED 2019
Uptake and Perception to Contraceptives by Adolescents Immediate Postpartum and Postabortal at MTRH, Eldoret Kenya. My Role: Supervisor
2. Sahara Omar – Reg No: SM/PGRH/04/14 MMED 2019
Emergency Contraception and Ectopic Pregnancy at Moi Teaching and Referral Hospital, Eldoret, Kenya My Role: Supervisor
3. Vincent N Oyiengo SM/PGRGO/02/15 Clinical Fellowship 2018 Antepartum Cervical Cancer Screening Using Visual Inspection with Acetic Acid in A Low Resource Setting Among HIV Positive and Negative Women at Moi Teaching and Referral Hospital Kenya. My role: Supervisor
4. Namugga Jane -Reg. No. SM/ PGRGO/02/14 Clinical Fellowship 2017
Dr Omenge Orang’o May 2020
14
A cross sectional study of clinical accuracy of care HPV DNA testing among women in western Kenya. My role: Supervisor
5. Jakait Nancy Akisa -SPH/PGH/05/12 MPH 2017 Awareness of Cervical Cancer Risk Factors and Utilization of Pap Smear Screening Among Primary School Female Teachers in Teso North Sub-County My role: Supervisor
6. Caren Chepkemoi Langat- SN/PGMNH/04/12 M.Sc. Nursing 2017
Women’s Experiences and Satisfaction with Antenatal Care at Moi Teaching and Referral Hospital, Eldoret, Kenya My role: Supervisor
7. Waweru James Munene- SM/PGRH/05/12 MMED 2017
Characteristics of stillbirths delivered at Moi Teaching and Referral Hospital, Eldoret by a candidate My role: Examined thesis
8. Janepher Namarome Masai- SN/PGMNH/06/12 M.Sc. Nursing 2017
An Assessment of Pre-Eclampsia Screening Services During the Antenatal Care Visits at Bungoma County Referral Hospital, Kenya My role: Marked thesis
9. Mwaniki Nyambura Grace- SPH/PGH/NC/1016/11 MPH 2016 Thesis: Knowledge and Utilisation of Emergency Contraception Among University Students: A Case Study of The University of Nairobi Female Undergraduate Students My role: Supervisor
10. Kereri Deborah Kemunto- SN/PGMNH/06/13 M.Sc. Nursing 2016
Thesis: Maternal Involvement in Neonatal Pain Treatment in The Newborn Unit of Rift Valley Provincial Hospital-Kenya. My role: Marked thesis
11. Okumu Michael- SN/PGMNH/04/13 M.Sc. Nursing 2016
Comparison of Birth Preparedness and Complications Readiness Among Women Receiving Group and Individual Prenatal Care in Gem County, Kenya. My role: Marked thesis
12. Wambugu Naomi Wairimu- SPG/PGH/NC/1003/12 MPH 2016
HIV Status Disclosure and Determinants of Adherence to Antiretroviral Therapy Among HIV Positive Adolescents at Comprehensive Care Clinic, Gertrude’s Children’s’ Hospital My role: Marked thesis
Dr Omenge Orang’o May 2020
15
13. Ngoran Grace Bongban- SN/PGMNH/08/13 M.Sc. Nursing 2016 Knowledge and skills retention among health providers trained on advanced life support in obstetrics in Cameroon. My role: Marked thesis
14. Deborah Kerubo Otore SPH/PGH/28/11 MPH 2015 Thesis: A Survey of Cervical Cancer Screening by HIV Status among Women attending Webuye AMPATH Clinic My role: Supervisor
15. Emmy C. Soi -SM/PGRH/02/10 MMED 2015
Thesis: Reproductive health needs of women prisoners in Langa’ta women prison, Nairobi, Kenya
My role: Supervisor
16. Mokua Juley-Anne Bochaberi- SPH/PGH/16/10 MPH 2015
Thesis: Impact of Birth Preparedness and Complication Readiness (Bp/Cr) On Utilization of Skilled Birth Attendance in Wareng District My role: Supervisor
17. Wycliffe Kosgei- SM/PGH/05/10 MMED 2015 Assessment of Post-abortal Care at Moi Teaching and Referral Hospital, Eldoret, Kenya. My role: Marked thesis
18. Monica Limo- SPH/PGH/24/10 MPH 2015 Utilization of Antenatal Care Services by Pregnant Women in The First Trimester in Kosirai Division, Nandi County, Kenya. My role: Marked thesis
19. Muwoli Felistus Dokowa- SN/PGMNH/03/12 M.Sc. Nursing 2015
Management and Outcomes of Obstetric Labour At Nkhotakota District Hospital, Malawi My role: Marked thesis
20. Doris Nthenya Mbithi MMED 2015
Thesis: Clinicopathologic findings of cervical cancer among HIV negative and positive patients seen at Moi Teaching and Referral Hospital My role: Supervisor
21. Erin Dainty Master of Science in Global Health 2013
Thesis: Screening for Cervical Cancer in HIV Positive Kenyan Women: The Role of HPV Genotyping
My role: supervisor
22. John Tolo Boston Otieno- SPH/PGH/17/08 MPH 2013
Thesis: The association between maternal factors and perinatal birth outcomes at Moi Teaching and Referral hospital, Eldoret, Kenya
Dr Omenge Orang’o May 2020
16
My role: Supervisor
23. Elijah K. Kirop – SGM/PGMHN/03/07 M.Sc. Nursing 2010
Male participation in Prevention of mother to Child Transmission (PMTCT) of HIV: Perspectives of Men, Women, and Health Care Providers in Trans-Nzoia District.
My role: Examined thesis.
Research Grant Support.
A. Active Grants
1. Brown/Moi Training Program for the Prevention and Treatment of HIV related Cervical Cancer- Grant number 1D43TW011317-01 My Role: CO- Principal Investigator Funding agency: National Institute of Health (NIH) Type: D43- International Research Training Award Period: 16/04/2019- 31/03/2024 Cost: $ 1,499,189 Our specific aims are: Aim# 1. To train a multidisciplinary cadre of Kenyan researchers working on the intersection of HIV and cervical cancer. To develop a new generation of talented and dedicated Kenyan investigators committed to HIV and cervical cancer research. To recruit and train highly promising Kenyan scholars (2 PhD, 4 Master’s students). To provide seed funding and ongoing mentorship for graduates to initiate new research projects in Kenya.
Aim# 2. To strengthen the capacity of Kenyan faculty and researchers to conduct research in HIV and cervical cancer screening, prevention and treatment by offering medium term training. This will encompass clinical,
epidemiologic, behavioral, implementation, laboratory capacity and basic science research. We also aim to increase the number of Kenyan women scientists.
AIM# 3. To establish annual symposiums/workshops for research on HIV and cervical cancer based in Kenya, for dissemination of research findings, professional networking and enhancing research projects. To host one-week
Dr Omenge Orang’o May 2020
17
training workshops in collaboration with Moi/AMPATH and Kenyan Ministry of Health (MOH) (grant writing, manuscript writing, novel research areas).
2. AMPATH-Oncology Institute: HPV and Cervical Cancer in Kenyan Women with HIV/AIDS
My Role: Principal Investigator (PI) Funding Agency: NIH Type: U54 Period: 19/9/2014- 31/8/2019 Cost: $728,206 (Project Total) This project aims to assess the results of cryotherapy and LEEP among VIA positive HIV- and HIV+ women in western Kenya. Modifiable risk factors that lead to treatment failure and HPV types (persistence and alterations) also will be assessed.
3. Novel concepts for cervical cancer screening in two rural African regions Gondar, Amhara region, Ethiopia and Eldoret, Kenya)
My Role: Co-Investigator Funding agency: Germany Ministry of Higher Education (BMBF-Programme) Cost: $ 238,429 Primary HPV testing is the most effective risk screening tool with a very high sensitivity, but less high specificity due to spontaneous clearance of the infection especially in young women. An increasing amount of studies underline that CINtec®PLUS is the most accurate disease marker having high sensitivity and specificity to detect the pre-cancer stage. Our aim is to compare the performance of VIA with HPV and CINtec®PLUS. To a cohort of about 800 eligible women aged 18 years or above attending one of two clinics in the Uasin-Gishu County of Kenya we will offer concurrent screening with HPV DNA test, CINtec®PLUS and VIA conducted by a trained nurse.
4. Home Based Self-Collected Vaginal Swabs for HPV Testing.
My Role: Co-Investigator Funding Agency Abbie Foundation
Type: Grant Period: 01/09/2015- 31/08/2016
Cost: $150,000. Through this project we aim to provide knowledge and cervical cancer screening to all women in the Chulaimbo region. The FLTR program that is already in place within AMPATH in Western Kenya represents an ideal opportunity to determine if individualized education and encouragement to go for screening at the household level will impact a population with an extremely high risk of developing and dying from cervix cancer.
5. Leeping Ahead: See and Leep training for primary care providers in Kenya.
Dr Omenge Orang’o May 2020
18
My Role: Principal Investigator Funding Agency: CFAR/PepFAR Supplement Type: P30 Period: 4/4/2014- 31/3/2015 (Now on no cost extension) Cost: $632,221 (Project Total) The aims of this project are: 1: To demonstrate the feasibility and operationalization of training 50 Kenyan Primary Care Providers (nurses, registrars, primary care physicians) to perform cervical cancer screening with VIA and treatment with LEEP in HIV-infected women in western Kenya; 2: To assess the safety and acceptability of LEEP performed by Kenyan Primary Care Providers on HIV-infected women. Aim 2 will include 400 HIV-infected women with abnormal VIA needing LEEP.
6. Taking a LEEP! Implementing a “See and LEEP” strategy for women in Western Kenya with positive cervical cancer screening.
My Role: Principal Investigator. Funding Agency: Grand Challenges Canada Type: Period: Cost: CAD 94,380 We propose a “See and LEEP” strategy in rural Kenya to provide a point-of-need service for women with a positive cancer screen. LEEP is highly effective at treating pre-malignant disease, has low morbidity and can be used in a low-resource setting.
7. Building Capacity for Cervical Cancer Prevention in Western Kenya.
My Role: Principal Investigator Funding Agency Princess Margaret Hospital Foundation (“PMH”). Type: University of Toronto project number 0560013914 and
fund number 471041. Period: Cost: CAD 83,756.80 The funds are to support the implementation of AMPATH-CCSP - to support
data collection, research infrastructure and clinic
expansion of AMPATH Cervical Cancer Screening
Program (CCSP) in western Kenya.
8. Association of cryotherapy with HIV-1 RNA genital shedding. (Awarded September 2013)
My Role: Principal Investigator Funding Agency: Centre for AIDS Research (CFAR) supplement Type: CFAR Supplement Period: 1/09/2013- 31/8/2014 (Now on no cost extension) Cost: Total direct cost awarded $50,000. This is a study whose aim is to evaluate changes in HIV-1 RNA viral load in the blood and genital tract of HIV infected women before and after cryotherapy for cervical neoplasia. The specific aims being: 1a: To evaluate the prevalence of HIV-1 RNA shedding in blood and genital tract before and after cryotherapy, comparing women on HAART and not on HAART.
Dr Omenge Orang’o May 2020
19
1b. To assess the change in quantity of HIV-1 RNA in blood and genital tract before and after cryotherapy, comparing women on HAART and not on HAART. 1c. To evaluate the persistence of HIV-1 RNA genital shedding after cryotherapy.
9. Outcomes of Excisional Treatment for Cervical Neoplasia in HIV Infected and HIV Uninfected Women in Western Kenya.
My Role: Principal Investigator
Funding Agency: NIH/NIAID
Type: Centre For AIDS Research (CFAR) International Developmental Research Award P30AI042853
Period: 1/10/2013- 30/9/2014 (Now on no cost extension) Cost: Total direct costs $25,000
This is a study whose aim is to compare treatment outcomes after LEEP for cervical neoplasia in HIV infected and HIV uninfected women in Eldoret, Kenya We also hope to determine predictors of treatment failure after surgical excision procedure for cervical neoplasia in HIV infected and HIV uninfected women.
B. Completed Grant projects
1. Cervical cancer See and treat: How Best to follow up. My Role: Principal investigator Funding Agency: NIH Type: CFAR/Pepfer supplement. Period: 1/4/2012- 31/3/2013 Cost: Total direct cost $ 271,593
This was a study whose aim was to assess how best to follow up women undergoing VIA and treated with cryotherapy.
2. The IU Simon Cancer Centre (IUSCC) AMPATH-Oncology Institute (AOI): An
Exemplar of Care for the Developing World and a Population-based Research Environment for IUSCC. Role: Co-Investigator and Member Walther Oncology Research Team.
Funding Agency: WALTHER Foundation WCF #: 0110.01. Period: 1/7/2012- 30/6/2015
3. Emergency Obstetrical Training (EmOC) in Western Kenya My Role: Principal Investigator Funding Agency: British Council. Type: DelPHE round four projects Period: 1/9/2009- 31/8/2012 Çost: Total project fund £90,000. Partners: Moi University / Moi Teaching and Referral Hospital, Kenya. - University of Toronto, Canada. - Makerere University, Uganda - The
Dr Omenge Orang’o May 2020
20
Association of Obstetricians and Gynaecologists of Uganda, Uganda – The Society of Obstetricians and Gynaecologists of Canada, Canada Summary/ Aim: The proposed intervention, Advances in Labour and Reducing Mortality (ALARM) – International Programme (AIP) training, will help the Ministry of Health implement the Kenya Essential Package for Health (KEPH) in western Kenya. Final report has been written and submitted to the funding agency through the British Council.
4. WHO Pilot Study to Assess the Feasibility of Medicines in Pregnancy
Registry. My Role: Co- Principal Investigator This protocol developed an approach to understanding the potential for
teratogenicity of medicines used on a wide-scale in resource-limited settings. ACTs for malaria served as the initial focus. A key objective was to collect high-quality evidence that would be sufficient to reinforce or change current antimalarial drug policy recommended by WHO regarding use of the artemisinins in pregnancy.
5. Ampath Cervical Cancer Screening Program (ACCSP)
My Role: Principal Investigator Funding Agency: Pfizer Foundation Period: 1/1/2009 (Multiple year)
Cost: $100,000 Cervical Cancer Screening Program includes the training of ancillary health care providers in cervical screening, as well as machines for the performance of colposcopy and cryotherapy for the treatment of dysplastic appearing lesions. We employ a see and treat strategy. Clients are screened by use of Visual inspection with Acetic acid (VIA) and those found to have abnormal epithelium (Acetowhite) are treated with cryotherapy. This is a cost-effective approach in resource-constrained setting like Kenya.
6. Screening for Cervical Cancer in HIV-Positive Kenyan Women: The Role of
Human Papillomavirus Typing.
Role: Co-Investigator.
Funding Agency: Duke Centre for AIDS Research
Period: 1/9/2013- 31/8/2014
Cost:
This was a funded study that aimed to describe the prevalence of HPV
genotypes in HIV infected women who are candidates for cryotherapy and
those with biopsy-confirmed severe dysplasia and invasive cervical cancer in
Eldoret, Kenya. Manuscript is under development.
Editorial Services Journal Reviewer
• Journal of Women’s Health
• PLOS ONE
Dr Omenge Orang’o May 2020
21
• The Lancet Global Health. PROFESSIONAL SOCIETIES
1. Kenya Medical Association (KMA) 2. Kenya Obstetric and Gynecological Society (KOGS) 3. International Gynecologic Cancer Society (IGCS) 4. Member Royal College of Obstetrics and Gynecology.
HOBBIES Soccer; travelling; photography Referees Prof Edwin Were Professor of Obstetrics and Gynaecology Department of Reproductive Health Moi University School of Medicine Prof Winstone Nyandiko Associate Professor of Child health and Paediatrics Department of Child Health and Paediatrics Moi University School of Medicine.